These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 35262639)

  • 1. Once Viewed as a Promising COVID-19 Treatment, Convalescent Plasma Falls Out of Favor.
    Rubin R
    JAMA; 2022 Mar; 327(12):1115-1116. PubMed ID: 35262639
    [No Abstract]   [Full Text] [Related]  

  • 2. Convalescent plasma therapy: A passive therapy for an aggressive COVID-19.
    Sahu KK; Jindal V; Siddiqui AD; Cerny J; Gerber JM
    J Med Virol; 2020 Nov; 92(11):2251-2253. PubMed ID: 32437024
    [No Abstract]   [Full Text] [Related]  

  • 3. Convalescent Plasma: A Potential Life-Saving Therapy for Coronavirus Disease 2019 (COVID-19).
    Alghamdi AN; Abdel-Moneim AS
    Front Public Health; 2020; 8():437. PubMed ID: 32903641
    [No Abstract]   [Full Text] [Related]  

  • 4. Convalescent plasma to treat COVID-19: Following the Argentinian lead.
    Tiberghien P; Toussirot E; Richard P; Morel P; Garraud O
    Transfus Apher Sci; 2021 Jun; 60(3):103161. PubMed ID: 34045121
    [No Abstract]   [Full Text] [Related]  

  • 5. Convalescent plasma for COVID-19 considerations.
    Adiwinata Pawitan J
    Transfus Apher Sci; 2021 Feb; 60(1):102927. PubMed ID: 32878733
    [No Abstract]   [Full Text] [Related]  

  • 6. [Is convalescent plasma an alternative treatment for Covid-19 patients?].
    Trejo-Gómor JE; Dimas-González J; Lagunas-Martínez A
    Salud Publica Mex; 2020; 62(6):870-871. PubMed ID: 33620985
    [No Abstract]   [Full Text] [Related]  

  • 7. Convalescent plasma to treat COVID-19: clinical experience and efficacy.
    Pei S; Yuan X; Zhang Z; Yao R; Xie Y; Shen M; Li B; Chen X; Yin M
    Aging (Albany NY); 2021 Mar; 13(6):7758-7766. PubMed ID: 33735836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WHO covid-19 drugs guideline: reconsider using convalescent plasma.
    Paneth N; Casadevall A; Pirofski LA; Henderson JP; Grossman BJ; Shoham S; Joyner MJ
    BMJ; 2022 Feb; 376():o295. PubMed ID: 35135758
    [No Abstract]   [Full Text] [Related]  

  • 9. COVID-19: Herd immunity and convalescent plasma transfer therapy.
    Syal K
    J Med Virol; 2020 Sep; 92(9):1380-1382. PubMed ID: 32281679
    [No Abstract]   [Full Text] [Related]  

  • 10. Convalescent Plasma for Covid-19 - Making Sense of the Inconsistencies.
    Estcourt L; Callum J
    N Engl J Med; 2022 May; 386(18):1753-1754. PubMed ID: 35507487
    [No Abstract]   [Full Text] [Related]  

  • 11. Convalescent Plasma for Covid-19. Reply.
    Sullivan DJ; Gebo KA; Hanley DF
    N Engl J Med; 2022 Sep; 387(10):955-956. PubMed ID: 36069884
    [No Abstract]   [Full Text] [Related]  

  • 12. Convalescent plasma for COVID-19. TSUNAMI is not the final word.
    Franchini M; Focosi D; Casadevall A; Joyner MJ; Perotti C
    Eur J Intern Med; 2022 Mar; 97():116-118. PubMed ID: 35031215
    [No Abstract]   [Full Text] [Related]  

  • 13. Convalescent Plasma for Covid-19.
    Joyner MJ; Pirofski LA
    N Engl J Med; 2022 Sep; 387(10):955. PubMed ID: 36069882
    [No Abstract]   [Full Text] [Related]  

  • 14. Convalescent Plasma for Covid-19.
    Paneth N
    N Engl J Med; 2022 Sep; 387(10):955. PubMed ID: 36069883
    [No Abstract]   [Full Text] [Related]  

  • 15. Measuring accuracy of the neutralizing activity of COVID-19 convalescent plasma.
    Franchini M; Mengoli C; Caruso B; Petilino R; Ballotari A; Glingani C
    Clin Chem Lab Med; 2022 Jan; 60(1):e4-e6. PubMed ID: 34472761
    [No Abstract]   [Full Text] [Related]  

  • 16. Convalescent Plasma for the Treatment of COVID-19: Perspectives of the National Institutes of Health COVID-19 Treatment Guidelines Panel.
    Pau AK; Aberg J; Baker J; Belperio PS; Coopersmith C; Crew P; Grund B; Gulick RM; Harrison C; Kim A; Lane HC; Masur H; Sheikh V; Singh K; Yazdany J; Tebas P;
    Ann Intern Med; 2021 Jan; 174(1):93-95. PubMed ID: 32976026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Convalescent Plasma in the Management of COVID-19.
    Dandachi D; Khalaf SA
    Mo Med; 2021; 118(2):118. PubMed ID: 33840851
    [No Abstract]   [Full Text] [Related]  

  • 18. COVID-19, Hypercoagulability, and Cautiousness with Convalescent Plasma.
    Sanfilippo F; La Rosa V; Oliveri F; Astuto M
    Am J Respir Crit Care Med; 2021 Jan; 203(2):257-258. PubMed ID: 33085908
    [No Abstract]   [Full Text] [Related]  

  • 19. Heterogeneity in COVID-19 Convalescent Plasma Clinical Trials.
    Müller-Olling M; Vahlensieck U; Hilger A
    Clin Pharmacol Ther; 2022 May; 111(5):995-1000. PubMed ID: 34139028
    [No Abstract]   [Full Text] [Related]  

  • 20. Thinking more about therapy with convalescent plasma for COVID-19 patients.
    Han G; Zhou YH
    Hum Vaccin Immunother; 2020 Nov; 16(11):2601-2603. PubMed ID: 32643512
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.